Northwest Biotherapeutics | NWBO - Umsatzerlöse





Der Umsatz Veränderung Datum
Agenus USD 33.7M 500K 2026-03
AstraZeneca USD 15.38B 90M 2026-06
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
Celldex Therapeutics USD 22K 7K 2026-06
Eisai JPY 234.33B 28.9B 2026-06
Merck USD 16.6B 310M 2026-06
Northwest Biotherapeutics USD 494K 294K 2026-03
Pfizer USD 15.03B 530M 2026-06
Plus Therapeutics USD 1.03M 339K 2026-03
Roche Holding CHF 30.36B 14.71B 2026-06